ALLO
Allogene Therapeutics, Inc. · Healthcare
Director Franz B Humer sold $26K of Allogene Therapeutics, Inc.
Sold$26,181
$2.34Price
11,200Shares
−4%Stake
What ALLO did after the filing
- The stock from Mon, Jun 3 close, $2.51
- +36.3%
- S&P 500, same days
- +5.9%
Measured over 30 trading days, to the Jul 17 close.
Traded Thu, May 30. Filed Mon, Jun 3, 12:09 PM ET, during the session. Returns use the Jun 3 close and the Jul 17 close. Not investment advice.